Sabra Health Care REIT Inc. (SBRA) Insider Trading: What Insights Can Be Gained?

As of Friday close, Sabra Health Care REIT Inc.’s (NASDAQ:SBRA) stock was down -$0.08, moving down -0.62 percent to $12.78. The average number of shares traded per day over the past five days has been 2,694,340 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.43 fall in that time frame. In the last twenty days, the average volume was 2,822,095, while in the previous 50 days, it was 2,760,242.


Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored


Since last month, SBRA stock retreated -0.62%. Shares of the company fell to $11.44 on 05/02/22, the lowest level in the past month. A 52-week high of $19.01 was reached on 03/29/22 after having rallying from a 52-week low of $11.44. Since the beginning of this year, SBRA’s stock price has dropped by -5.61% or -$0.76, and marked a new high 6 times. However, the stock has declined by -32.79% since its 52-week high.

Sabra Health Care REIT Inc. (SBRA) last reported insider trading activity 136 days ago on Dec 29. Andrews Harold W. Jr., the Executive VP, CFO & Secretary of the company, disposed of 110,000 shares for $13.55 on Dec 29. It resulted in a $1,490,742 divestment by the insider.

Valuation Metrics

The stock’s beta is 1.42. Besides these, the trailing price-to-sales (P/S) ratio of 5.31, the price-to-book (PB) ratio of 0.88.

The latest dividend of $0.30 per share was paid out, remained unchanged from last year’s $0.30. On Wednesday May 6 2020, a $0.15 dividend decrease was announced.

Financial Health

According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.70, and the total debt-to-equity ratio was 0.70. On the profitability front, the trailing twelve-month gross margin is 79.40% percent. In the year ended September 29, operating margins totaled 13.00%. Based on annual data, SBRA earned $201.25 million in gross profit and brought in $569.54 million in revenue.

In Sabra Health Care REIT Inc.’s quarter-end financial report for September 29, it reported total debt of $50.65 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. SBRA’s revenue rose 6.58% to $135.66 million during the quarter, while net income inched up to $163.11 million. While analysts expected Sabra Health Care REIT Inc. to report $0.14 quarterly earnings, the actual figure was $0.05 per share, beating the consensus estimate by -64.30%. During the quarter, the company generated $114.12 million in EBITDA. The value of shareholders’ equity is $230.96 million.

Technical Picture

This quick technical analysis looks at Sabra Health Care REIT Inc.’s (SBRA) price momentum. With a historical volatility rate of 54.14%, the RSI 9-day stood at 51.37% on 13 May.

With respect to its five-day moving average, the current Sabra Health Care REIT Inc. price is down by -3.26% percent or -$0.43. At present, SBRA shares trade -1.39% below its 20-day simple moving average and +2.32% percent above its 100-day simple moving average. However, the stock is currently trading approximately -4.98% below its SMA50 and -31.58% below its SMA200.

Stochastic coefficient K was 62.14% and Stochastic coefficient D was 61.10%, while ATR was 0.49. Given the Stochastic reading of 62.76% for the 14-day period, the RSI (14) reading has been calculated as 49.06%. As of today, the MACD Oscillator reading stands at -0.05, while the 14-day reading stands at 0.29.

Analyst Ratings

Sabra Health Care REIT Inc. downgraded its rating on Sabra Health Care REIT Inc. (NASDAQ: SBRA) to an Equal weight in a note to investors on April 18, 2022. The analysts firm previously had an Overweight rating on the stock.Sabra Health Care REIT Inc. (SBRA) has been rated Overweight by analysts. According to 0 brokerage firms , SBRA is a sell, and 8 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Sabra Health Care REIT Inc. stock as buy, with 7 recommending it as overweight.

With a median target price of $16.00, the current consensus forecast for the stock is $14.00 – $17.00. Based on these forecasts, analysts predict Sabra Health Care REIT Inc. (SBRA) will achieve an average price target of $15.60.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles